Genomics

Dataset Information

De Novo Pyrimidine Synthesis Is a Collateral Metabolic Vulnerability in NF2-deficient Mesothelioma


ABSTRACT: De Novo Pyrimidine Synthesis Is a Collateral Metabolic Vulnerability in NF2-deficient Mesothelioma

PROVIDER: PRJNA1255527 | ENA |

REPOSITORIES: ENA

Similar Datasets